VIDEO | Top of page |
PRN no longer offers CME or ABIM MOC. | Top of page |
About the Presenter: | Top of page |
Learning Objectives: | Top of page |
1. Be aware of markers that may help predict who among people on ART may have better chances to control viremia if ART is discontinued for any reason.
2. Understand the viral and host factors that have been associated with post-treatment control, as well as the immune mechanisms mobilized during acute infection vs treatment interruption.
3. Know the difference between HIV remission and HIV cure.
4. Understand how post-treatment controllers are different (or are not) from other cases of durable remission or potential HIV cure.
Disclosure Statement: | Top of page |
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Joseph P. McGowan (Moderator) has no relevant financial relationships to disclose.
- Dr. Asier Sáez-Cirión (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Merck, and ViiV; Honoraria from Merck, Gilead, and ViiV. Dr. Sáez-Cirión submitted his slides in advance for adequate peer review and supported his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.